Rising Prevalence Of Infectious Diseases Fuels Growth In The Metagenomic Sequencing Market Outlook Driver: Leading Transformation in the Metagenomic Sequencing Market Outlook in 2025

What Are the Projected Growth and Market Size Trends for the Metagenomic Sequencing Market?
There has been a swift expansion of the metagenomic sequencing market in the past few years. Its value is projected to rise from $2.13 billion in 2024 to $2.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.5%. The considerable growth seen historically is due to factors such as the increased involvement of the government, a rising number of research projects involving metagenome sequencing, expanded uses of metagenomics in genomics and diagnostics research, the availability of financial resources for research, and the advancement of NGS data analysis tools.

Expectations are for the metagenomic sequencing market to experience swift expansion in the coming years. Projections reveal a growth up to $4.71 billion in 2029 with a compound annual growth rate (CAGR) of 17.1%. The growing period is likely to be driven by factors such as reducing computational expenses, increasing interest in finding new biomolecules, high-throughput sequencing technologies becoming more common, the need for personalized medicine and disease diagnosis, and a rise in infectious diseases. The forecasted period is expected to see trends like advanced innovations, the use of advanced genomic technologies by metagenomics, enhanced funding for research and development, progress in sequencing technology, and big data utilised for NGS data analysis.

What Are the Key Drivers Behind the Growth of the Metagenomic Sequencing Market?
The rise in the occurrence of infectious diseases is predicted to propel the expansion of the metagenomic sequencing market. Such diseases are conditions brought about by harmful microorganisms like bacteria, viruses, parasites, or fungi that can be transmitted, either directly or indirectly, from one individual to another. The growing incidence of illnesses that compromise the immune system, such as HIV/AIDS, treatments for cancer, and autoimmune diseases, can render people more vulnerable to infectious diseases. Metagenomic sequencing provides a robust and adaptable method to examine infectious diseases, offering crucial information on variations in pathogens, how they spread, resistance to antimicrobial drugs, and the monitoring of outbreaks. For example, the report issued by the Government of Canada, a Canada-based federal authority in January 2023, showed that there were 135 rabies samples received in October 2022 and 159 rabies samples in November 2022. Moreover, the Centers for Disease Control and Prevention, a US government agency, reported in March 2023 that tuberculosis (TB) cases in the US had risen by 5.9% from 7,874 cases in 2021 to 8,331 cases in 2022. Thus, the increasing occurrence of infectious diseases is propelling the metagenomic sequencing market's growth.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp

Which Leading Companies Are Shaping the Growth of the Metagenomic Sequencing Market?
Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

What Are the Major Trends Shaping the Metagenomic Sequencing Market?
Major corporations operating in the metagenomic sequencing market are dedicated to innovation in sequencing services, with the goal of enhancing sequencing precision, throughput, and cost-efficiency. Sequencing services allude to advanced genomic techniques capable of sequencing lengthier DNA fragments, offering a more inclusive glimpse of genetic structures in contrast to conventional short-read methods. For instance, Clinical Microbiomics A/S, a biotech firm situated in Denmark, introduced sophisticated long-read sequencing services in April 2024, comprising 16S, ITS, 18S rRNA, custom gene sequencing, and extensive genomics and metagenomics. These provide unmatched clarity and quality in microbial analysis, granting deep understanding into microbial communities and fostering the formation of high-quality metagenome-assembled genomes.

What Are the Key Segments of the Metagenomic Sequencing Market?
The metagenomic sequencing market covered in this report is segmented -

1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions
2) By Technology: 16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics
3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications

Subsegments:
1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes)
2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments
3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing
4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Which Region Dominates the Metagenomic Sequencing Market?
North America was the largest region in the metagenomic sequencing market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Metagenomic Sequencing Global Market Report?

- Market Size Analysis: Analyze the Metagenomic Sequencing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Metagenomic Sequencing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Metagenomic Sequencing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Metagenomic Sequencing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16117

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.